Answer
Apr 30, 2025 - 12:08 PM
Inderal LA, a long-acting formulation of propranolol, was discontinued due to a combination of factors including decreased demand, the availability of generic alternatives, and potentially strategic business decisions by the manufacturer. These factors collectively contributed to its withdrawal from the market, although the immediate medical need for propranolol can still be met by other formulations.
